Related content

Immunotherapy of MHC class I-deficient tumors

By Reiniš Milan  

Future Oncology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1577-1589

Future Medicine

Access to resources Recommend Favorite

Molecular Abnormalities Associated with Endocrine Tumors of the Uterine Cervix

By Wistuba I.I.   Thomas B.   Behrens C.   Onuki N.   Lindberg G.   Albores-Saavedra J.   Gazdar A.F.  

Gynecologic Oncology, Vol. 72, Iss. 1, 1999-01 ,pp. : 3-9

Elsevier

Access to resources Recommend Favorite

Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients

By                        

International Journal of Oncology, Vol. 40, Iss. 4, 2012-01 ,pp. : 965-974

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells

By                      

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1585-1590

Spandidos Publications

Access to resources Recommend Favorite

HLA class I antigen abnormalities and immune escape by malignant cells

By Seliger B.   Cabrera T.   Garrido F.   Ferrone S.  

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 3-13

Academic Press

Access to resources Recommend Favorite